Induction of cells differentiation and ABC transporters expression by a myco-estrogen, zearalenone, in human choriocarcinoma cell line (BeWo)

Toxicology

Volumn 263, Issue 2-3, 2009, Pages 100-107

  Prouillac, Caroline ^a   Videmann, Bernadette ^a   Mazallon, Michelle ^a   Lecoeur, Sylvaine ^a  

^a VETAGRO SUP   (France)

Author keywords

ABC transporter; Food contaminant; Placenta; Trophoblast differentiation; Zearalenone

Indexed keywords

ABC TRANSPORTER; BREAST CANCER RESISTANCE PROTEIN; CHORIONIC GONADOTROPIN; ESTRADIOL; FORSKOLIN; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; ZEARALENONE;

ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CHORIOCARCINOMA; CONTROLLED STUDY; EXPOSURE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HORMONE RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNCYTIUM; TROPHOBLAST;

ATP-BINDING CASSETTE TRANSPORTERS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL SURVIVAL; CHORIOCARCINOMA; COLORING AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; ESTRADIOL; ESTROGENS, NON-STEROIDAL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FORSKOLIN; HUMANS; PREGNANCY; TETRAZOLIUM SALTS; THIAZOLES; TIME FACTORS; TROPHOBLASTS; ZEARALENONE;

ANIMALIA; FUSARIUM;

EID: 68549107569     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2009.06.023     Document Type: Article

References (52)

1. Abid-Essefi S., Baudrimont I., Hassen W., Ouanes Z., Mobio T.A., Anane R., Creppy E.E., and Bacha H. DNA fragmentation, apoptosis and cell cycle arrest induced by zearalenone in cultured DOK, Vero and Caco-2 cells: prevention by vitamin E. Toxicology 192 (2003) 237-248
2. Abid-Essefi S., Ouanes Z., Hassen W., Baudrimont I., Creppy E.E., and Bacha H. Cytotoxicity, inhibition of DNA and protein syntheses and oxidative damage in cultured cells exposed to zearalenone. Toxicol. In Vitro 18 (2004) 467-474
3. Bechi N., Ietta F., Romagnoli R., Focardi S., Corsi I., Buffi C., and Paulesu L. Estrogen-like response to p-nonylphenol in human first trimester placenta and BeWo choriocarcinoma cells. Toxicol. Sci. 93 1 (2006) 75-81
4. Bennett J.W., and Klich M. Mycotoxins. Clin. Microbiol. Rev. 16 (2003) 497-516
5. Bernhoft A., Bchrens G.H., Ingebrigtsen K., Langseth W., Berndt S., Haugen T.B., and Grotmol T. Placental transfer of the estrogenic mycotoxin zearalenone in rats. Reprod. Toxicol. 15 5 (2001) 545-550
6. Bode C., Jin H., Rytting E., Silverstein P., Young A.M., and Audus K.L. In vitro models for studying trophoblast transcellular transport. Methods Mol. Med.: Placenta Trophobl.: Protoc. Methods 122 (2005) 225-239
7. Borges M., Bose P., Frank H.G., Kaufmann P., and Pôtgens J.G. A two-colour fluorescence assay for the measurement of syncytial fusion between trophoblast derived cell lines. Placenta 24 (2003) 959-964
8. Chaddha V., Viero S., Huppertz B., and Kingdom J. Developmental biology of the placenta and the origins of placental insufficiency. Semin. Fetal Neonatal Med. 9 (2004) 357-369
9. Cronier L., Hervé J.C., Délèze J., and Malassiné A. Regulation of gap junctional communication during human trophoblast differentiation. Microsc. Res. Technol. 38 (1997) 21-28
10. Cronier L., Alsat E., Hervé J.C., Délèze J., and Malassiné A. Dexamethasone stimulates gap junctional communication, peptide hormones production and differentiation in human term trophoblast. Trophobl. Res. 11 (1998) 35-49
11. Cronier L., Guibourdenche J., Nigera C., and Malassine A. Oestradiol stimulates morphological and functional differentiation of human villous cytotrophoblast. Placenta 20 (1999) 669-676
12. Cross J.C., Werb Z., and Fisher S.J. Implantation and the placenta: key pieces of the development puzzle. Science 266 (1994) 1508-1518
13. Cygalova L., Ceckova M., Pavek P., and Staud F. Role of breast cancer resistance protein (Bcrp/Abcg2) in fetal protection during gestation in rat. Toxicol. Lett. 178 3 (2008) 176-180
14. Domingo J.L. Metal-induced developmental toxicity in mammals: a review. J. Toxicol. Environ. Health 42 2 (1994) 123-141
15. Egawa M., Kamata H., Kushiyama A., Sakoda H., Fujishiro M., Horike N., Yoneda M., Nakatsu Y., Ying G., Jun Z., Tsuchiya Y., Takata K., Kurihara H., and Asano T. Long-term forskolin stimulation induces ampk activation and thereby enhances tight junction formation in human placental trophoblast BeWo cells. Placenta 29 (2008) 1003-1008
16. Eriksen G.S., Pennington J., Schlatter J., Alexander J., and Thuvander A. Zearalenone. Joint FAO/WHOExpert Committee on Food Additives, Safety evaluation of certain food additives and contaminants. WHO Food Additives Series vol. 44 (2002), WHO, Geneva
17. Evseenko D., Paxton J.W., and Keelan J.A. Active transport across the human placenta: impact on drug efficacy and toxicity. Expert Opin. Drug Metab. Toxicol. 2 1 (2006) 51-69
18. Evseenko D.A., Paxton J.W., and Keelan J.A. ABC drug transporter expression and functional activity in trophoblast-like cell lines and differentiating primary trophoblast. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290 (2006) R1357-R1365
19. Gedeon C., Behravan J., Koren G., and Piquette-Miller M. Transport of glyburide by placental ABC transporters: implications in fetal drug exposure. Placenta 27 (2006) 1096-1102
20. Jin H., and Audus K.L. Effect of bisphenol A on drug efflux in BeWo, a human trophoblast-like cell line. Placenta 19 (2005) S96-S103
21. Kao L.C., Caltabiano S., Wu S., Strauss J.F., and Kliman H.J. The human villous cytotrophoblast: interactions with extracellular matrix proteins, endocrine function, and cytoplasmic differentiation in the absence of syncytium formation. Dev. Biol. 130 (1988) 693-702
22. Kliman H.J., Nestler J.E., Sermasi E., Sanger J.M., and Strauss J.F. Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placenta. Endocrinology 118 (1986) 1567-1582
23. Kuiper G.G.J.M., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., Van der Saag P.T., Van der Burg B., and Gustafsson J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor. Endocrinology 139 (1998) 4252-4263
24. Kumagai S., and Shimizu T. Neonatal exposure to zearalenone causes persistent anovulatory estrus in the rat. Arch. Toxicol. 50 (1982) 279-286
25. Lankas G.R., Wise L.D., Cartwright M.E., Pippert T., and Umbenhauer D.R. Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice. Reprod. Toxicol. 12 4 (1998) 457-463
26. Le Guevel R., and Pakdel F. Assessment of oestrogenic potency of chemicals used as growth promoter by in vitro methods. Hum. Reprod. 16 (2001) 1030-1036
27. Mason J.I., Ushijima K., doody K.M., Nagai K., Naville D., Head J.R., Milewich L., Rainey W.E., and Ralph M.M. Regulation of expression of the 3b-hydroxysteroid dehydrogenases of human placenta and fetal adrenal. J. Steroid Biochem. Mol. Biol. 47 (1993) 151-159
28. Mathias A.A., Hitti J., and Unadkat J.D. P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages. Am. J. Physiol. Regul. Integr. Comp. Physiol. 289 (2005) R963-R969
29. McBride W.G. Thalidomide and congenital abnormalities. Lancet 278 (1961) 1358
30. Minervini F., Giannoccaro A., Cavallini A., and Visconti A. Investigations on cellular proliferation induced by zearalenone and its derivatives in relation to the estrogenic parameters. Toxicol. Lett. 159 (2005) 272-283
31. Moe A.J., Furesz T.C., and Smith C.H. Functional characterization of l-alanine transport in a placental choriocarcinoma cell line (BeWo). Placenta 15 (1994) 797-802
32. Myllynen P., Pasanen M., and Vähäkangas K. The fate and effects of xenobiotics in human placenta. Expert Opin. Drug Metab. Toxicol. 3 (2007) 331-346
33. Ouanes Z., Ayed-Boussema I., Baati T., Creppy E.E., and Bacha H. Zearalenone induces chromosome aberrations in mouse bone marrow: preventive effect of 17β-estradiol, progesterone and Vitamin E. Mutat. Res. 565 (2005) 139-149
34. Pascolo L., Fernetti C., Pirulli D., Crovella S., Amoroso A., and Tiribellia C. Effects of maturation on RNA transcription and protein expression of four MRP genes in human placenta and in BeWo cells. Biochem. Biophys. Res. Commun. 303 (2003) 259-265
35. Pattillo R.A., and Gey G.O. The establishment of a cell line of human hormone-synthesizing trophoblastic cells in vitro. Cancer Res. 28 (1968) 1231-1236
36. Pavek P., Cerveny L., Svecova L., Brysch M., Libra A., Vrzal R., Nachtigal P., Staud F., Ulrichova J., Fendrich Z., and Dvorak Z. Examination of glucocorticoid receptor α-mediated transcriptional regulation of P-glycoprotein, CYP3A4, and CYP2C9 genes in placental trophoblast cell lines. Placenta 28 (2007) 1004-1011
37. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29 9 (2001) e45
38. Rama S., Petrusz P., and Raoa A.J. Hormonal regulation of human trophoblast differentiation: a possible role for 17β-estradiol and GnRH. Mol. Cell. Endocrinol. 218 (2004) 79-94
39. Sastry B.V. Techniques to study human placental transport. Adv. Drug Deliv. Rev. 38 (1999) 17-39
40. Schmid K.E., Davidson W.S., Myatt L., and Woollett L.A. Transport of cholesterol across a BeWo cell monolayer: implications for net transport of sterol from maternal to fetal circulation. J. Lipid Res. 44 (2003) 1909-1918
41. Shi Q.J., Lei Z.M., Rao C.V., and Lin J. Novel role of human chorionic gonadotropin in differentiation of human cytotrophoblasts. Endocrinology 132 3 (1993) 1387-1395
42. Stahl S., Chun T.Y., and Gray W.G. Phytoestrogen act as estrogen agonists in an estrogen-responsive pituitary cell line. Toxicol. Appl. Pharmacol. 152 (1998) 41-48
43. Sun M., Kingdom J., Baczyk D., Lyeb S.J., Matthews S.G., and Gibb W. Expression of the multidrug resistance P-glycoprotein (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation. Placenta 27 (2006) 602-609
44. Syme M.R., Paxton J.W., and Keelan J.A. Drug transfer and metabolism by the human placenta. Clin. Pharmacokinet. 43 8 (2004) 487-514
45. Ushigome F., Takanaga H., Matsuo H., Yanai S., Tsukimori K., Nakano H., Uchiumi T., Nakamura T., Kuwano M., Ohtani H., and Sawada Y. Human placental transport of vinblastine, vincristine, digoxin and progesterone: contribution of P-glycoprotein. Eur. J. Pharmacol. 408 (2000) 1-10
46. Utoguchi N., Chandorkar G.A., Avery M., and Audus K.L. Functional expression of P-glycoprotein in primary cultures of human cytotrophoblasts and BeWo cells. Reprod. Toxicol. 14 (2000) 217-224
47. Vardhana P.A., and Illsley N.P. Transepithelial glucose transport and metabolism in BeWo choriocarcinoma cells. Placenta 23 (2002) 653-660
48. Videmann B., Mazallon M., Tep J., and Lecoeur S. Metabolism and transfer of the mycotoxin zearalenone in human intestinal Caco-2 cells. Food Chem. Toxicol. 46 10 (2008) 3279-3286
49. Wang H., Zhou F., Gupta A., Vethanayagam R.R., Zhang Y., Unadkat J.D., and Mao Q. Regulation of BCRP/ABCG2 expression by progesterone and 17β-estradiol in human placental BeWo cells. Am. J. Physiol. Endocrinol. Metab. 290 (2006) E798-E807
50. Wice B., Menton D., Geuze H., and Schwartz A.L. Modulators of cyclic AMP metabolism induce syncytiotrophoblast formation in vitro. Exp. Cell. Res. 186 (1990) 306-316
51. Yasuda S., Itagaki S., Hirano T., and Iseki K. Effects of sex hormones on regulation of ABCG2 expression in the placental cell line BeWo. J. Pharm. Pharm. Sci. 9 1 (2006) 133-139
52. Zinedine A., Soriano J.M., Molto J.C., and Manes J. Review on the toxicity, occurrence, metabolism, detoxification, regulations and intake of zearalenone: an oestrogenic mycotoxin. Food Chem. Toxicol. 45 (2007) 1-18